S

SOM Biotech

16 employees

Drug innovation company based on a pioneering AI-based drug discovery technology, that has built a robust pipeline for Orphan CNS diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
In silico screening
Pre-clinical validation
Artificial Intelligence
Drug repurposing
Intellectual Property
Rare Diseases
Pharmaceutical
Orphan CNS indications
Licensing
Drug reprofiling
Health Care
Central Nervous System
Medical
Life Science

Date founded

2009

Funding rounds raised

Total raised

$2.2M

from 3 investors over 3 rounds

S

SOM Biotech raised undisclosed on January 1, 2021

Investors: Monte Carlo Capital

S

SOM Biotech raised undisclosed on July 1, 2017

Investors: Monte Carlo Capital

S

SOM Biotech raised $2.2M on February 2, 2017

Investors: Monte Carlo Capital

FAQ